Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation

Thyroid

Volumn 24, Issue 1, 2014, Pages 169-174

  Iyer, Pallavi ^a   Mayer, Jennifer L R ^b   Ewig, Jeffrey M ^c  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b SARASOTA MEMORIAL HOSPITAL   (United States)

^c Pediatric Pulmonary Associates   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GLUCOCORTICOID; IODINE 131; OSELTAMIVIR; PREDNISONE; SALBUTAMOL; SORAFENIB;

ARTIFICIAL VENTILATION; CANCER PATIENT; CASE REPORT; CERVICAL LYMPH NODE; CHILD; DIFFUSE NODULAR PULMONARY DISEASE; DRUG DOSE INCREASE; EXTUBATION; FEVER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; HYPOXEMIA; INFLUENZA A (H1N1); LUNG NODULE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; THERAPY DELAY; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TRACHEOSTOMY; TREATMENT RESPONSE; TUMOR VOLUME; WEDGE RESECTION;

ANOXIA; CARCINOMA; CHILD; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; NIACINAMIDE; PHENYLUREA COMPOUNDS; RESPIRATION, ARTIFICIAL; THYROID NEOPLASMS;

EID: 84892169229     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0468     Document Type: Review

References (21)

1. Hogan AR, Zhuge Y, Perez EA, et al. 2009 Pediatric thyroid carcinoma: Incidence and outcomes in 1753 patients. J Surg Res 156:167-172
2. Rivkees SA, Mazzaferri EL, Verburg FA, et al. 2011 The treatment of differentiated thyroid cancer in children: Emphasis on surgical approach and radioactive iodine therapy. Endocr Rev 32:798-826
3. Al-Tonbary Y, Zalata K, El-Ashry R, Fouda A 2009 Papillary thyroid carcinoma presenting with upper respiratory tract obstruction and pulmonary metastases. World J Pediatr 5: 229-231
4. Cooper DS, Doherty GM, Haugen BR, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
5. Hebestreit H, Biko J, Drozd V, et al. 2011 Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl. Eur J Nucl Med Mol Imaging 38:1683-1690
6. Capdevila J, Iglesias L, Halperin I, et al. 2012 Sorafenib in metastatic thyroid cancer. Endocr Relat Cancer 19:209-216
7. Hoftijzer H, Heemstra KA, Morreau H, et al. 2009 Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. Eur J Endocrinol 161:923-931
8. Xing M 2007 BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications. Endocr Rev 28:742-762
9. Wilhelm S, Carter C, Lynch M, et al. 2006 Discovery and development of sorafenib: A multikinase inhibitor for treating cancer. Nat Rev Drug Discov 5:835-844
10. Wilhelm SM, Adnane L, Newell P, et al. 2008 Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 7:3129-3140
11. Cabanillas ME, Waguespack SG, Bronstein Y, et al. 2010 Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: The M.D. Anderson experience. J Clin Endocrinol Metab 95:2588-2595
12. Kloos RT, Ringel MD, Knopp MV, et al. 2009 Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol 27:1675-1684
13. Lee EY, McAdam AJ, Chaudry G, et al. 2010 Swine-origin influenza a (H1N1) viral infection in children: Initial chest radiographic findings. Radiology 254:934-941
14. Vermeer-Mens JC, Goemaere NN, Kuenen-Boumeester V, et al. 2006 Childhood papillary thyroid carcinoma with miliary pulmonary metastases. J Clin Oncol 24:5788-5789
15. Hutten M, Lassay L, Sachs B, et al. 2009 Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma. Pediatr Dermatol 26: 349-350
16. Nageswara Rao AA, Scafidi J, Wells EM, Packer RJ 2012 Biologically targeted therapeutics in pediatric brain tumors. Pediatr Neurol 46:203-211
17. Rokes CA, Remke M, Guha-Thakurta N, et al. 2010 Sorafenib plus valproic acid for infant spinal glioblastoma. J Pediatr Hematol Oncol 32:511-514
18. Waguespack SG, Sherman SI, Williams MD, et al. 2009 The successful use of sorafenib to treat pediatric papillary thyroid carcinoma. Thyroid 19:407-412
19. Widemann BC, Fox E, Adamson PC, et al. 2009 Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I consorium trial. J Clin Oncol 27:abstr 10012
20. Kim DW, Jo YS, Jung HS, et al. 2006 An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. J Clin Endocrinol Metab 91:4070-4076
21. Marotta V, Guerra A, Sapio MR, Vitale M 2011 RET/PTC rearrangement in benign and malignant thyroid diseases: A clinical standpoint. Eur J Endocrinol 165:499-507